Joshua C. Pritchett, M.D.

Joshua C. Pritchett, M.D., is a scholar in the Mayo Clinic Kern Center for the Science of Health Care Delivery.

Resident, Hematology and Oncology

Instructor in Medicine, Mayo Clinic College of Medicine and Science

What moment or experience in your life influenced your decision to be a clinician?

For as long as I can remember, I've had a deep desire to connect with and care for others. Rather than a single moment or experience, I think this desire matured over time and carried me toward a career in medicine. I cannot imagine doing anything else.

When I entered medical school, I had planned on pursuing a career in primary care. Just before I began my studies, my mother-in-law was diagnosed with metastatic colon cancer. Through her journey, I developed a passion for the field of hematology and oncology. This set the course for a career as a physician who gets to care for patients with cancer every day.

What motivated you to become a Kern Health Care Delivery Scholar?

During my residency training I developed an interest in high-dimensional data analysis and was on a pathway toward becoming a translational physician-scientist. However, as I moved down this path, I felt increasingly distant from my original passion for patient care and clinical practice.

In addition, as I continued to care for my own patients and loved ones with cancer, I became convinced of the need for research and innovation to bring about a more patient-centered model of cancer care delivery. Out of this conviction, I began to pursue opportunities to leverage my background in data analytics to meet these challenges.

In the midst of this professional evolution, I've found a home within the Kern Health Care Delivery Scholars Program, where I have the opportunity to learn from world-class mentors and develop additional tools to help advance the field of cancer care delivery.

What is your focus as a scholar within the Mayo Clinic Kern Center for the Science of Health Care Delivery?

My focus is on the design and implementation of innovative patient-centered approaches to the delivery of cancer care. Specifically, my team and I are designing a home-based, multi-disciplinary, remote patient-monitoring program to care for patients with cancer and neutropenic fever.

Tell us about your mentoring team.

  • Tufia C. Haddad, M.D., is an oncologist and digital health innovator. She provides leadership to multiple digital health and innovation programs at Mayo Clinic.
  • Jon C. Tilburt, M.D., is a leader in the field of health care delivery. His work is focused on improving care and human connection in health systems.
  • Aaron L. Leppin, M.D., is a researcher in the field of health care implementation. His research is focused on working with multiple stakeholders to implement innovations and improvements in health care.

How will your research improve patient care or impact public health?

The goal of this innovative remote patient-monitoring program is to forge a new paradigm in the management of a major clinical challenge — neutropenic fever — experienced by a significant proportion of patients with cancer.

Right now, patients with neutropenic fever are routinely admitted to the hospital for inpatient management, often leading to prolonged hospitalizations with accumulative risks and costs. This program will enable patients to continue to recover at home, while still providing evidence-based clinical management and oversight. I believe that the conscientious design and implementation of programs like this will serve as necessary steps toward the effective re-imagining of patient-centered cancer care delivery.

Why did you choose Mayo Clinic to pursue your career?

Mayo Clinic is a community of world-class clinicians, educators, researchers, innovators and care team members all dedicated to one common goal: delivering extraordinary care for our patients. This same core value has guided my own journey into medicine, and it is an incredible privilege to work and grow alongside others with a shared guiding principle.